| Role of Salivary Biomarkers in Oral Cancer Detection |
30 |
| Glutathione as a Marker for Human Disease |
23 |
| Acute phase reactant serum amyloid A in inflammation and other diseases |
20 |
| Tissue and Blood Biomarkers in Lung Cancer: A Review |
19 |
| Fecal Calprotectin |
15 |
| New biomarkers in endometriosis |
12 |
| Glycosylation markers in cancer |
12 |
| Free Circulating miRNAs Measurement in Clinical Settings: The Still Unsolved Issue of the Normalization |
11 |
| Liquid Biopsy: From Basic Research to Clinical Practice |
11 |
| Protein Carbamylation: Chemistry, Pathophysiological Involvement, and Biomarkers |
10 |
| Long Noncoding RNAs: Advances in Lipid Metabolism |
10 |
| Adiponectin and Its Isoforms in Pathophysiology |
10 |
| Blood Glucose Determination: Effect of Tube Additives |
8 |
| Selenium in Complicated Pregnancy. A Review |
8 |
| Proteomics for Biomarker Identification and Clinical Application in Kidney Disease |
7 |
| Circulating microRNA in cardiovascular disease |
7 |
| Telomeres in neurological disorders |
6 |
| Extracellular vesicle-associated MMPs: A modulator of the tissue microenvironment |
6 |
| Recent advances in the determination of insulins from biological fluids |
6 |
| Metabolomics and Lipidomics of Ischemic Stroke |
6 |
| Advances in oral cancer detection |
5 |
| Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases |
5 |
| A practical guide to validation and verification of analytical methods in the clinical laboratory |
5 |
| The Proteome of Cataract Markers: Focus on Crystallins |
5 |
| Toward a holistic approach for diagnosing sepsis in the emergency department |
5 |
| Titin fragment in urine: A noninvasive biomarker of muscle degradation |
4 |
| Novel glomerular filtration markers |
4 |
| Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease |
4 |
| Advances in PCOS Pathogenesis and Progression-Mitochondrial Mutations and Dysfunction |
4 |
| Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition |
4 |
| Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practice |
4 |
| Pentraxin-3 and endothelial dysfunction |
4 |
| Advances in HER2 testing |
4 |
| Advances in celiac disease testing |
4 |
| Advances in DNA/RNA detection using nanotechnology |
3 |
| Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides |
3 |
| Locked Nucleic Acid Technology for Highly Sensitive Detection of Somatic Mutations in Cancer |
3 |
| Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual |
3 |
| Advances in biomarker detection: Alternative approaches for blood-based biomarker detection |
3 |
| Distribution of Fatty Acids and Lipids During Pregnancy |
3 |
| Inflammatory Response During Myocardial Infarction |
2 |
| Phosphaturia in kidney stone formers: Still an enigma |
2 |
| Advances in monitoring anticoagulant therapy |
2 |
| Emicizumab (ACE910): Clinical background and laboratory assessment of hemophilia A |
2 |
| New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men |
2 |
| Proteomics of reproduction: Prospects and perspectives |
2 |
| Laboratory assessment of multiple myeloma |
2 |
| The chemical and laboratory investigation of hemolysis |
2 |
| Protein Carbamylation in Chronic Kidney Disease and Dialysis |
2 |
| Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers |
2 |
